FDA Investigator Rebecca L Stephany
Rebecca L Stephany has conducted inspections on 14 sites in 1 countries as of 12 Sep 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
12 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Rebecca L Stephany:
Althea A Williams,
Amanda S Zorn,
Andrea A Branche,
Andrew S Johnson,
Anya Dlockett Evans,
Ashleigh P Wodushek,
Bryan J Love,
CDR Sean T Creighton,
Charles D Brown,
Charles L Larson,
Christine I Shaw,
Christopher D Rush,
Christopher S Genther,
Daniel J Lahar,
David A Quale,
Dennis G Kawabata,
Gary L Zaharek,
Ginger M Sykes,
Grant L Davis,
Hamed Ghoda,
Harmon M Blanch,
Ian J Thomson,
Iris C Macinnes,
James R Montero,
Janet B Abt,
Janet Pulver,
Jeanne M Weishaar,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer W Cheng Dobson,
Jocelyn T Ramos,
John R Myung,
Juanj N Wu,
Justin H Erickson,
Kimberly Lewandowski Walker,
Lauren E Skokan,
Linda F Murphy,
Lori J Silverstein,
Marc A Jackson, Jr,
Marc R Dickens,
Mark E Moen,
Matthew M Vernon,
Nancy A Saxenian Emmons,
Nancy Bogdanovic,
Nathan R Moon,
Nicholas R Nance,
Philip M Steele, PhD,
Phillip M Pontikos,
Ricki A Chase,
Roy Baby,
Scott K Zika,
Scott R Nichols, PhD,
Stanley B Eugene, BS, BME,
Thai T Duong,
Thomas C Mclean, CFS,
Vicky L Cruz,
Yvonne M Larsen
Rebecca L Stephany's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2022 | FDA 483 | Rapid Reboot Recovery Products, LLC - Form 483, 2022-09-08 |
September, 2022 | FDA 483 | Hoggan Scientific LLC - Form 483, 2022-09-30 |
October, 2022 | FDA 483 | Motion Control, Inc. - Form 483, 2022-10-19 |
July, 2022 | FDA 483 | Mytrex, Inc. - Form 483, 2022-07-19 |
March, 2022 | FDA 483 | Chemtron Biotech, Inc - Form 483, 2022-03-18 |
September, 2021 | FDA 483 | Viper Technologies, LLC dba Avalign Thortex - Form 483, 2021-09-24 |
August, 2022 | FDA 483 | B & D Dental Corp. - Form 483, 2022-08-16 |
May, 2022 | FDA 483 | Pyrexar Medical, Inc. - Form 483, 2022-05-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more